Lichenoid Eruption During Chronic Hepatic C Treatment with Interferon-Alpha 2 a Plus Ribavirin

被引：0
作者：
Sahnoun, R. [1 ]
Kastalli, S. [1 ]
Charfi, O. [1 ]
Zaiem, A. [1 ]
Lakhal, M. [1 ]
Daghfous, R. [1 ]
El Aidli, S. [1 ]
机构：
[1] Natl Ctr Pharmacovigilance, Tunis, Tunisia
来源：
DRUG SAFETY | 2013年 / 36卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：869 / 869
页数：1
相关论文
共 50 条
  • [21] Outcomes of treatment of hepatitis C cirrhosis with pegylated interferon-alpha and ribavirin
    Kong, J.
    Kontorinis, N.
    Studd, C.
    Tarquinio, L.
    Nazareth, S.
    McInerney, M.
    Cheng, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A293 - A294
  • [22] Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin. A case report.
    Weegink, CJ
    Molenaar, DS
    Chamuleau, RA
    Reesink, HW
    HEPATOLOGY, 2000, 32 (04) : 565A - 565A
  • [23] A Comparison of Interferon alpha-2a Plus Ribavirin Combination Therapy with Peginterferon alpha-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
    Demiraslan, Hayati
    Aygen, Bilgehan
    Yildiz, Orhan
    Soyuer, Isin
    Gokahmetoglu, Selma
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2008, 13 (01): : 12 - 22
  • [24] Efficacy and tolerability of pegylated interferon alpha-2a plus ribavirin versus pegylated interferon alpha-2b plus ribavirin, in treatment naive chronic hepatitis C patients
    Lee, S. Y.
    Lee, S.
    Ko, K. S.
    Kim, I. H.
    Kim, S. H.
    Kim, S. W.
    Lee, S. O.
    Lee, S. T.
    Kim, D. G.
    Choi, C. S.
    Cho, E. Y.
    Kim, H. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A176 - A176
  • [25] Alterations of soluble transferrin receptor level in children with chronic hepatitis C during treatment with recombinant interferon-alpha and ribavirin
    Mozer-Lisewska, I
    Mania, A
    Kowala-Piaskowska, A
    Figlerowicz, M
    Sluzewski, W
    HEPATOLOGY RESEARCH, 2005, 33 (01) : 19 - 23
  • [26] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
  • [27] Virological and biochemical response to combined interferon-alpha plus ribavirin therapy in patients with chronic hepatitis C.
    Kessler, HH
    Pierer, K
    Fickert, P
    Stauber, RE
    GASTROENTEROLOGY, 1997, 112 (04) : A1300 - A1300
  • [28] Two patients with chronic psychotic disorders who completed interferon-alpha plus ribavirin therapy for hepatitis C
    Drozdz, W.
    Kozielewicz, D.
    Dybowska, D.
    Halota, W.
    Borkowska, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S490 - S491
  • [29] Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a
    Bell, H
    Hellum, K
    Harthug, S
    Myrvang, B
    Ritland, S
    Mæland, A
    von der Lippe, B
    Bjoro, K
    Skaug, K
    Gutigard, BG
    Raknerud, N
    Simmonds, P
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 (02) : 194 - 198
  • [30] TREATMENT OF CHRONIC HEPATITIS-C WITH INTERFERON-ALPHA
    MARCELLIN, P
    BENHAMOU, JP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1991, 15 (8-9): : 613 - 614
12345